Search results
Results from the WOW.Com Content Network
When blinatumomab was approved, Amgen announced that the price for the drug would be US$178,000 per year, which made it the most expensive cancer drug on the market. Merck's pembrolizumab was priced at US$150,000 per year when it launched (in September 2014). [ 15 ]
In 2010, Alexion priced Soliris as the most expensive drug in the world, [27] at approximately US$409,500 a year in the United States (2010), [27] €430,000 per year for ongoing treatment in the UK, [28] [29] and $500,000 a year in Canada (2014). [30] In 2021, Soliris generated US$1.874 billion in sales. [31] [32]
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and vaccines from France's ...
breast cancer: Herceptin 6981 7013 9 bevacizumab: colon cancer: Avastin 6847 6686 10 rituximab: non-Hodgkin's lymphoma: Rituxan, MabThera 6750 7298 11 rivaroxaban: anticoagulant: Xarelto 6589 6234 12 aflibercept: Eylea 6551 5830 13 infliximab: Remicade 5908 7152 14 Pneumococcal conjugate vaccine: Prevnar 13 Prevenar 13 5802 5601 15 ustekinumab ...
Drug price-comparison platform GoodRx recently released an expanded rundown of the 20 most costly drugs in the U.S., based on the list price set by manufacturers — which can be very different ...
Developed by Alexion Pharmaceuticals, Soliris is the most expensive drug in the world, at an average annual cost of $409,500. Soliris itself treats a rare blood disorder called paroxysmal ...
The Cancer Drugs Fund (CDF) was introduced in England in 2011. ... Avastin is the most frequently requested treatment. Kadcyla is the most expensive drug funded.
For premium support please call: 800-290-4726 more ways to reach us